YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer to hike price of COVID antiviral Paxlovid

Posted online

Pfizer CEO Albert Bourla announced the company would hike the price of COVID-19 antiviral treatment Paxlovid.

The price of the drug currently is $530 for a treatment course. The new price has not been released, but one analyst said in a media report that it could go up to as much as $2,500 per course.

Pfizer earlier this year raised the prices of COVID-19 vaccines by more than fourfold.

Read more from Ars Technica.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences